Curia | Empowering Cancer Patients

We aim to save lives and extend survival of cancer patients by building a trusted community of patients, loved ones and healthcare providers

Every patient should feel empowered to be the decision-maker in their cancer journey. CURIATM seeks to empower patients, along with their doctors throughout their treatment journey providing the most critical accurate, unbiased, and comprehensive information. It offers patients several ways to be involved with the cancer community – by engaging with others who have cancer and allowing them to get involved directly in research.

Curia Features


Find treatments that match your cancer profile.

Find treatments based on the answers you gave in the questionnaire.
Save treatments in your favorites for easy access.
Explore and learn about available off-label treatments.

Clinical Trials

Browse and apply to clinical trials around the world.

View details of ongoing trials, such as the phase and eligibility criteria.
Choose a trial site and apply for enrollment directly in the app.
Save trials in your favorites for easy access.


Locate and contact experts who specialize in your type of cancer.

Explore from a list of experts near you.
Get the expert’s contact information.
Know the expert’s medical affiliation.

Cancer Twin

Find your Cancer Twin.

Connect with up to 3 patients with the most similar cancer profile as you.
Share, learn and empower each other through a private chat.
Decide to stay anonymous or share your profile with your Twin.

Info Feed

Find curated content to assist your treatment.

Access curated articles, blogs, audio, and videos, as well as other resources.
Spread awareness by sharing these with loved ones.
Lifestyle-related support.

previous arrow
next arrow

About Us


We are facilitating the journey of patients, caregivers and loved-ones by providing time-critical information.


Using AI to share accurate, unbiased and comprehensive information that is specific to cancer type and stage.


The patient is at the heart of our solutions. We are developing a system based on patient needs.

Our goal is to empower the patients throughout their journey!

We are turning information into knowledge, providing second opinions to create independence
and finally giving the patients the power to decide about their data themselves!

Blog Impressions


  • Which indications are available in the app?
    Currently, CURIATM has information about Breast cancer, Cholangiocarcinoma, Colorectal cancer, Endometrial cancer, Esophageal cancer, Gall bladder cancer, Gastric cancer, Liver cancer, Lung cancer, Melanoma, Osteosarcoma, Ovarian cancer, Pancreatic cancer, Prostate cancer, Renal cancer, Soft tissue sarcoma, Cervical cancer, Thyroid cancer, Bladder cancer, Testicular cancer, Penile cancer, Hodgkin lymphoma and Multiple myeloma. More cancer indications are added to the app over time.
  • How does CURIATM select the treatments, clinical trials, and experts available in the app?

    CURIATM is unbiased in sourcing information, taking information from reliable official sources.

    Cancer treatments approved for countries in which CURIATM is available are in the app, including on and off-label therapies.

    Experts available in the app are selected according to a broad range of criteria including time in practice, participation in scientific research, and institution type. The CURIATM app includes oncology experts for all indications available in the app, and for all countries for which CURIATM is available.

    All clinical trials in phase 2 and 3 are available in the app, updated in near real-time. Some phase 1 trials are included when they are inherently combined with phase 2.

  • I submitted a clinical trial application and haven’t heard back for a while. What do I do?
    It can take up to 3 weeks to be matched or rejected with a clinical trial. Under My Trial Application, you’ll see a tag which shows the current status of your application. Click the tag to see a detailed time estimate for each step of your application. Has it been more than 3 weeks? Send us a message using our contact form.
  • Where can I submit comments and remarks on the app?
    Please submit all comments and remarks using our contact form. We’re always happy to hear from our users and a member of our team will get back to you as soon as possible.
  • How is CURIATM financed?
    CURIATM is a subsidiary part of OncoCoin AG and financed by, Innoplexus AG, a German company that uses AI in life sciences.
  • How do I know the results in the app are objective?
    We have different ways to make sure we keep the information in CURIATM as objective as possible. Treatments are sorted in alphabetic order and trials and experts are sorted by distance.
  • How is my data protected?
    All of our data is encrypted according to the highest industry encryption standards. We will not share any user data to third parties without the user’s consent.
  • How often is the data for the app updated?
    Once new treatments are approved, they will be visible in the app within 1-3 days. Clinical Trials are updated in near real-time.
  • Where does CURIATM data come from?
    We make sure the CURIATM app only shows data collected from reliable, validated sources. Such sources include regulatory bodies, clinical trial registries and hospital websites.
  • Featured in

    2020 Gold Award Winner

    Get in touch!

    If you are a user of our app who wants to provide feedback
    or if you are interested in becoming part of our team – just let us know!

    Reach out over email